Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 4UNKNOWN 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Endocrine 2

Conditions

Postoperative Complications 1Polycystic Ovary Syndrome 1Pituitary Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Metabolic Syndrome 1Insulin Resistance 1Hypopituitarism 1Dwarfism, Pituitary 1Atherosclerosis 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Growth Hormone × Clear all
NCT03717168 2019-08-21

Effects of Growth Hormone on Difficult Ventilator Weaning Patients

National Cancer Institute, Egypt

Phase 2 Completed
60 enrolled

Postoperative Complications

NCT01853566 2014-09-03

Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old

Universidade Federal do Rio de Janeiro

Phase 4 Completed
13 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1

NCT00518635 2013-02-20

Low Dose Growth Hormone in Obese PCOS Women

Oregon Health and Science University

Phase NA Withdrawn

Insulin Resistance, Polycystic Ovary Syndrome

NCT00462475 2007-10-16

5yrGH

Federico II University

Completed
20 enrolled
Endocrine

Dwarfism, Pituitary, Hypopituitarism, Pituitary Neoplasms, Metabolic Syndrome, Atherosclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡